BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, offering promising developments throughout various healthcare and industrial apps. With its structural similarity to In a natural way derived human serum albumin, OsrHSA provides a safer, more trustworthy alternative for therapeutic